跳至主要内容
临床试验/CTRI/2020/04/024557
CTRI/2020/04/024557尚未招募2 期

Randomized double blinded placebo controlled clinical study to evaluate the efficacy of Darchini (Cinnamomum zeylanicum Blume)in the Management of dyslipidemia

Jamia Hamdard0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
Jamia Hamdard

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 20-65 years.
  • 2. Patient of all genders.
  • 3. Patient willing to participate and sign the written informed consent.
  • 4. Known cases of dyslipidemia with any one of the following
  • ï?? Total Cholesterol Level >200 mg/dl
  • ï?? Low-Density Lipoprotein Cholesterol Level >130mg/dl
  • ï?? High-Density Lipoprotein <40mg/dl

排除标准

  • 1.Age below 20 and above 65 years.
  • 2.Serum Triglycerides Level >1000mg/dl.
  • 3.Pregnant and lactating women
  • 4.Patients suffering from CKD, CAD, CLD, thyroid disorder, active tuberculosis.
  • 5.Uncontrolled DM ( HbA1C >7 ), uncontrolled Hypertension
  • 6.Known case of immune-compromised status.
  • 7.The patient using lipid-lowering drugs or dietary supplements with the last 3 months.
  • 8.Oral contraceptives & corticosteroids.
  • 9.Use of alcohol or any other drug abuse.
  • 10.Neurological disorders like epilepsy or psychiatric disorders.

研究者

发起方
Jamia Hamdard

相似试验